Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 21097-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- PRAS40 antibody
- Antibody type
- Polyclonal
- Description
- PRAS40 antibody (Cat. #21097-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Pharmacological inhibition of PGK1 suppresses EGFR-positive esophageal squamous cell carcinoma by dual targeting of glycolysis and autophagy-dependent EGFR degradation.
Clinical significance and potential molecular mechanisms of SYT15 expression in lung adenocarcinoma.
mTOR/miR-142-3p/PRAS40 signaling cascade is critical for tuberous sclerosis complex-associated renal cystogenesis.
Hypothalamic SLC7A14 accounts for aging-reduced lipolysis in white adipose tissue of male mice.
Silencing Glypican-1 enhances the antitumor effects of Pictilisib via downregulating PI3K/Akt/ERK signaling in chemo-resistant esophageal adenocarcinoma.
Sexually dimorphic extracellular vesicle responses after chronic spinal cord injury are associated with neuroinflammation and neurodegeneration in the aged brain.
The Molecular Landscape and Biological Alterations Induced by PRAS40-Knockout in Head and Neck Squamous Cell Carcinoma.
Ge J, Chen Y, Jiang Z, Qi S, Hu J, Wang B, Wang A, Liu Q, Wu H, Wang W, Liu J
Cellular oncology (Dordrecht, Netherlands) 2026 Apr 29;49(3)
Cellular oncology (Dordrecht, Netherlands) 2026 Apr 29;49(3)
Clinical significance and potential molecular mechanisms of SYT15 expression in lung adenocarcinoma.
Tian M, Deng L, Jin L, Qiang X, Li Y, Liu X, Wang H, Wang X, Wu N
Scientific reports 2025 Dec 17;16(1):2554
Scientific reports 2025 Dec 17;16(1):2554
mTOR/miR-142-3p/PRAS40 signaling cascade is critical for tuberous sclerosis complex-associated renal cystogenesis.
Zhao S, Hao S, Zhou J, Chen X, Zhang T, Qi Z, Zhang T, Jalal S, Zhai C, Yin L, Bo Y, Teng H, Wang Y, Gao D, Zhang H, Huang L
Cellular & molecular biology letters 2024 Sep 27;29(1):125
Cellular & molecular biology letters 2024 Sep 27;29(1):125
Hypothalamic SLC7A14 accounts for aging-reduced lipolysis in white adipose tissue of male mice.
Jiang X, Liu K, Luo P, Li Z, Xiao F, Jiang H, Wu S, Tang M, Yuan F, Li X, Shu Y, Peng B, Chen S, Ni S, Guo F
Nature communications 2024 Sep 11;15(1):7948
Nature communications 2024 Sep 11;15(1):7948
Silencing Glypican-1 enhances the antitumor effects of Pictilisib via downregulating PI3K/Akt/ERK signaling in chemo-resistant esophageal adenocarcinoma.
Pratap A, Qualman A, Garrett H, Westbrook L, The E, Mitra S, Cordero M, Monge KM, Idrovo JP, Chauhan A, Cheng L, Cohen MJ, Mungo B, Wani S, Meguid RA, McCarter MD, Meng X
Molecular & cellular oncology 2023;10(1):2238873
Molecular & cellular oncology 2023;10(1):2238873
Sexually dimorphic extracellular vesicle responses after chronic spinal cord injury are associated with neuroinflammation and neurodegeneration in the aged brain.
Li Y, Khan N, Ritzel RM, Lei Z, Allen S, Faden AI, Wu J
Journal of neuroinflammation 2023 Aug 31;20(1):197
Journal of neuroinflammation 2023 Aug 31;20(1):197
The Molecular Landscape and Biological Alterations Induced by PRAS40-Knockout in Head and Neck Squamous Cell Carcinoma.
Chen G, Li Z, Chen C, Liu J, Zhu W, She L, Huang H, Qin Y, Liu G, Wang J, Liu Y, Huang D, Tang Q, Zhang X, Zhu G
Frontiers in oncology 2020;10:565669
Frontiers in oncology 2020;10:565669
No comments: Submit comment
No validations: Submit validation data